| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 01/27/2011 | US20110023195 Engineering single-gene-controlled staygreen potential into plants |
| 01/27/2011 | US20110023194 Engineering zymogen for conditional toxicity |
| 01/27/2011 | US20110023186 Method for modifying plant morphology, biochemistry and physiology |
| 01/27/2011 | US20110023185 Novel Plant Acyltransferases Specific For Long-Chained, Multiply Unsaturated Fatty Acids |
| 01/27/2011 | US20110023180 Novel hydroxyphenylpyruvate dioxygenase polypeptides and methods of use |
| 01/27/2011 | US20110023177 Genetically Modified Plants Displaying Reduced Accumulation of Cadmium |
| 01/27/2011 | US20110023156 Feline genome editing with zinc finger nucleases |
| 01/27/2011 | US20110023153 Genomic editing of genes involved in alzheimer's disease |
| 01/27/2011 | US20110023150 Genome editing of genes associated with schizophrenia in animals |
| 01/27/2011 | US20110023149 Genomic editing of genes involved in tumor suppression in animals |
| 01/27/2011 | US20110023141 Genomic editing of genes involved with parkinson's disease |
| 01/27/2011 | US20110023139 Genomic editing of genes involved in cardiovascular disease |
| 01/27/2011 | US20110023138 Mammalian artificial chromosome vector comprising human cytochrome p450 gene (cluster) and non-human mammalian animal retaining the same |
| 01/27/2011 | US20110023137 Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof |
| 01/27/2011 | US20110023135 Use of a new gene coding for a new member of the mcm2-8 family in pharmaceutical compositions |
| 01/27/2011 | US20110021790 Producing biofuels using polyketide synthases |
| 01/27/2011 | US20110021768 B12-Dependent Dehydratases With Improved Reaction Kinetics |
| 01/27/2011 | US20110021767 B12-Dependent Dehydratases With Improved Reaction Kinetics |
| 01/27/2011 | US20110021610 Aromatic prenyltransferase from hop |
| 01/27/2011 | US20110021546 Gene Defects And Mutant ALK Kinase In Human Solid Tumors |
| 01/27/2011 | US20110021541 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 01/27/2011 | US20110021448 Inhibitors for the Soluble Epoxide Hydrolase |
| 01/27/2011 | US20110021444 Compositions for controlling hair growth |
| 01/27/2011 | US20110021416 Compositions, methods and uses for treating bacterial infections |
| 01/27/2011 | US20110021383 Apparatuses for real-time, single molecule sequence determination |
| 01/27/2011 | US20110021378 Nucleic acids of pichia pastoris and use thereof for recombinant production of proteins |
| 01/27/2011 | US20110020938 Recombinant expression plasmid vector and recombinant strain to be used in producing oxalate decarboxylase, and method of producing recombinant oxalate decarboxylase |
| 01/27/2011 | US20110020900 Lactobacillus acidophilus nucleic acid sequences encoding protease homologues and uses therefore |
| 01/27/2011 | US20110020899 Glucoamylase variants with altered properties |
| 01/27/2011 | US20110020898 Thermostable Nucleic Acid Polymerase From Thermococcus Gorgonarius |
| 01/27/2011 | US20110020897 Rna-dependent dna polymerase from geobacillus stearothermophilus |
| 01/27/2011 | US20110020896 Mutant dna polymerases and their genes |
| 01/27/2011 | US20110020895 Methods and compositions for determining isomerase enzymatic activity |
| 01/27/2011 | US20110020892 Composition |
| 01/27/2011 | US20110020881 Method of producing biofuel using brown algae |
| 01/27/2011 | US20110020878 Method of Removing Nucleic Acid Contamination in Reverse Transcription and Amplification Reactions |
| 01/27/2011 | US20110020877 Cren7 chimeric protein |
| 01/27/2011 | US20110020875 Hydrogenase polypeptide and methods of use |
| 01/27/2011 | US20110020870 Methods for producing modified glycoproteins |
| 01/27/2011 | US20110020868 Bacterial leader sequences for increased expression |
| 01/27/2011 | US20110020851 Novel glucose dehydrogenase |
| 01/27/2011 | US20110020824 Methods and compositions for quantitative amplification and detection over a wide dynamic range |
| 01/27/2011 | US20110020823 Sequences and their use for detection and characterization of e. coli o157:h7 |
| 01/27/2011 | US20110020798 Novel italy, LOR-2, strife, trash, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor |
| 01/27/2011 | US20110020469 Aminopyrimidines useful as kinase inhibitors |
| 01/27/2011 | US20110020424 Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds |
| 01/27/2011 | US20110020377 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110020376 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110020353 Antibodies and related molecules that bind to 161p2f10b proteins |
| 01/27/2011 | US20110020341 Novel multidrug resistance-associated polypeptide |
| 01/27/2011 | US20110020327 Purification of proteins |
| 01/27/2011 | US20110020315 Treatment of inflammatory illnesses with ace2 |
| 01/27/2011 | US20110020311 Therapy of multiple sclerosis, inflammatory neurological diseases and neurodegenerative diseases with 5'-deoxyadenosylcobalamin, growth hormone, immunomodulators, interleukins, other therapeutic agents, and physiotherapy |
| 01/27/2011 | US20110020273 Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof |
| 01/27/2011 | US20110017595 Biosensor Membranes Composed of Polymers Containing Heterocyclic Nitrogens |
| 01/27/2011 | CA2768897A1 Fermentative glycerol-free ethanol production |
| 01/27/2011 | CA2768857A1 Porphyranases, and use thereof for hydrolyzing polysaccharides |
| 01/27/2011 | CA2768851A1 Inhibitors of mtor kinase as anti-viral agents |
| 01/27/2011 | CA2768608A1 Improved host cell for the production of a compound of interest |
| 01/27/2011 | CA2768593A1 A method of removing nucleic acid contamination in reverse transcription and amplification reactions |
| 01/27/2011 | CA2768042A1 Raf dimers and uses thereof |
| 01/26/2011 | EP2278025A1 Method for evaluation of degree of malignancy of tumor cell |
| 01/26/2011 | EP2278018A2 Nucleic acid sequences encoding proteins associated with abiotic stress response |
| 01/26/2011 | EP2278017A1 A method of selectively producing male or female sterile plants |
| 01/26/2011 | EP2278016A1 Promoter sequences derived from Fusarium Venenatum and uses thereof |
| 01/26/2011 | EP2278015A1 Method of producing a carbohydrate ester |
| 01/26/2011 | EP2278013A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2278002A1 Processes for the manufacture of sterilized pancreatin powder |
| 01/26/2011 | EP2278001A1 Protease variants and compositions |
| 01/26/2011 | EP2278000A1 Lipase variant |
| 01/26/2011 | EP2277999A1 Lipase variant |
| 01/26/2011 | EP2277998A1 Urate oxidase |
| 01/26/2011 | EP2277997A2 Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same |
| 01/26/2011 | EP2277989A1 Fermentative glycerol-free ethanol production |
| 01/26/2011 | EP2277920A2 Inhibitors of complement activation |
| 01/26/2011 | EP2277897A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2277552A1 Mnk kinase proteins and diabetes |
| 01/26/2011 | EP2276854A1 Cidea modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 01/26/2011 | EP2276835A1 Process for the preparation of a phospholipase |
| 01/26/2011 | EP2276830A1 Functional enhancement of yeast to minimize production of ethyl carbamate via modified transporter expression |
| 01/26/2011 | EP2276499A2 Recombinant deamidated gliadin antigen |
| 01/26/2011 | EP1865056B1 Gene expression cassette and transformant, and process for production of 2-deoxy-scyllo-inosose and process for purification of 2-deoxy-scyllo-inosose using the transformant |
| 01/26/2011 | EP1851310B1 Crystal structure of tak1-tab1 |
| 01/26/2011 | EP1615612B1 Pro-urokinase mutant for lysis of occlusive blood clots while sparing wound sealing clots in the treatment of stroke |
| 01/26/2011 | EP1603511B1 Treatment of igai deposition diseases |
| 01/26/2011 | EP1602722B1 Process for producing microbial transglutaminase |
| 01/26/2011 | EP1539956B1 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/26/2011 | EP1445323B1 Process for producing glutamic acid derivatives |
| 01/26/2011 | EP1405668B1 Novel separation agent for separating optical isomer and method for preparation thereof |
| 01/26/2011 | EP1349946B1 Plant polynucleotides encoding prenyl proteases |
| 01/26/2011 | CN1965076B Modulation of WRN-mediated telomere-initiated cell signaling |
| 01/26/2011 | CN1829798B Protease, DNA coding for the protease and process for producing the protease |
| 01/26/2011 | CN1807610B Method for producing low temperature cellulase using microbe fermentation |
| 01/26/2011 | CN101960013A High level expression and accumulation of heterologous polypeptide in plant tissue |
| 01/26/2011 | CN101960008A Polypeptides having lipase activity and polynucleotides encoding same |
| 01/26/2011 | CN101960007A Detergent composition comprising lipase |
| 01/26/2011 | CN101960006A Expression of catalase in trichoderma |
| 01/26/2011 | CN101955968A Constitutive expression plasmid pETPc with high startup strength, fast startup speed and wide host range and application thereof |
| 01/26/2011 | CN101955967A Constitutive expression plasmid pMMPc with high start strength and wide host range and application thereof |
| 01/26/2011 | CN101955966A High starting intensity and wide host range constitutive expression plasmid pBSPPc and application thereof |